Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1998 2
2001 2
2003 1
2004 1
2005 1
2007 1
2008 4
2009 1
2012 1
2013 4
2014 2
2015 2
2016 3
2017 4
2018 7
2019 9
2020 7
2021 4
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20JS, 5BAuthor
Page 1
Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.
Gray R, Patel S, Ives N, Rick C, Woolley R, Muzerengi S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE; PD MED Collaborative Group. Gray R, et al. JAMA Neurol. 2022 Feb 1;79(2):131-140. doi: 10.1001/jamaneurol.2021.4736. JAMA Neurol. 2022. PMID: 34962574 Free PMC article. Clinical Trial.
With regard to DRIs, participants in the MAO-B group had mean PDQ-39 mobility scores that were 4.2 points (95% CI, 0.4-7.9 points; P=.03) better than those of the COMT group and EuroQol 5-dimension 3-level (EQ-5D-3L) utility scores that were 0.05 points (95% CI, 0.003-0.09 …
With regard to DRIs, participants in the MAO-B group had mean PDQ-39 mobility scores that were 4.2 points (95% CI, 0.4-7.9 points; P=.03) be …
Quality of life in Cushing's syndrome.
Santos A, Crespo I, Aulinas A, Resmini E, Valassi E, Webb SM. Santos A, et al. Pituitary. 2015 Apr;18(2):195-200. doi: 10.1007/s11102-015-0640-y. Pituitary. 2015. PMID: 25647329 Review.
The CushingQoL questionnaire has been mapped to well-validated instruments like SF-36 or EQ-5D, and therefore may be used in cost-utility and other health economy studies....
The CushingQoL questionnaire has been mapped to well-validated instruments like SF-36 or EQ-5D, and therefore may be used in cost-uti …
COVID-19 and EQ-5D-5L health state valuation.
Webb EJD, Kind P, Meads D, Martin A. Webb EJD, et al. Eur J Health Econ. 2024 Feb;25(1):117-145. doi: 10.1007/s10198-023-01569-8. Epub 2023 Feb 23. Eur J Health Econ. 2024. PMID: 36814039 Free PMC article.
DATA: In Spring 2020, participants in a UK general population survey rated 2 EQ-5D-5L states, 11111 and 55555, as well as dead, using a visual analogue scale (VAS) from 100 = best imaginable health to 0 = worst imaginable health. ...CONCLUSION: The results complement previ …
DATA: In Spring 2020, participants in a UK general population survey rated 2 EQ-5D-5L states, 11111 and 55555, as well as dead, using …
Does a health crisis change how we value health?
Webb EJD, Kind P, Meads D, Martin A. Webb EJD, et al. Health Econ. 2021 Sep;30(10):2547-2560. doi: 10.1002/hec.4399. Epub 2021 Jul 23. Health Econ. 2021. PMID: 34302310 Free article.
We examine whether UK general population health valuations changed during the COVID-19 pandemic. Ratings of EQ-5D-5L health states 11111 (no problems), 55555 (extreme problems), and dead were collected in a UK general population survey during the pandemic (April-May 2020) …
We examine whether UK general population health valuations changed during the COVID-19 pandemic. Ratings of EQ-5D-5L health states 11 …
Personalized local SAR prediction for parallel transmit neuroimaging at 7T from a single T1-weighted dataset.
Brink WM, Yousefi S, Bhatnagar P, Remis RF, Staring M, Webb AG. Brink WM, et al. Magn Reson Med. 2022 Jul;88(1):464-475. doi: 10.1002/mrm.29215. Epub 2022 Mar 28. Magn Reson Med. 2022. PMID: 35344602 Free PMC article.
METHODS: Multi-contrast data were acquired at 7T (N = 10) to establish ground truth segmentations in eight tissue types. A 2.5D convolutional neural network was trained using the T1-weighted data as input in a leave-one-out cross-validation study. ...
METHODS: Multi-contrast data were acquired at 7T (N = 10) to establish ground truth segmentations in eight tissue types. A 2.5D convo …
The cost-effectiveness of early goal-directed therapy: an economic evaluation alongside the ARISE trial.
Higgins AM, Peake SL, Rinaldo Bellomo AO, Ao DJC, Delaney A, Howe BD, Nichol AD, Webb SA, Williams PJ, Harris AH; ARISE Investigators and the ANZICS Clinical Trials Group. Higgins AM, et al. Crit Care Resusc. 2023 Oct 18;23(3):329-336. doi: 10.51893/2021.3.OA10. eCollection 2021 Sep 6. Crit Care Resusc. 2023. PMID: 38046082 Free PMC article.
Outcome measures: Clinical outcomes included lives saved, life-years gained and quality-adjusted life-years (QALYs), with mortality collected until 12 months and health-related quality of life assessed at baseline, 6 and 12 months using the 3-level EuroQol five dimensions questio …
Outcome measures: Clinical outcomes included lives saved, life-years gained and quality-adjusted life-years (QALYs), with mortality collecte …
Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly.
Badia X, Trainer P, Biermasz NR, Tiemensma J, Carreño A, Roset M, Forsythe A, Webb SM. Badia X, et al. J Med Econ. 2018 Apr;21(4):382-389. doi: 10.1080/13696998.2017.1419960. Epub 2018 Jan 5. J Med Econ. 2018. PMID: 29261359 Free article.
AIMS: To estimate a preference-based single index for the disease-specific instrument (AcroQoL) by mapping it onto the EQ-5D to assist in future economic evaluations. MATERIALS AND METHODS: A sample of 245 acromegaly patients with AcroQoL and EQ-5D scores was obtain …
AIMS: To estimate a preference-based single index for the disease-specific instrument (AcroQoL) by mapping it onto the EQ-5D to assis …
An Item-Response Mapping from General Health Questionnaire Responses to EQ-5D-3L Using a General Population Sample from England.
Webb EJD. Webb EJD. Appl Health Econ Health Policy. 2023 Mar;21(2):327-346. doi: 10.1007/s40258-022-00767-4. Epub 2022 Nov 14. Appl Health Econ Health Policy. 2023. PMID: 36372819 Free PMC article.
OBJECTIVE: The aim of this study was to create an item-response mapping between GHQ-12 and EQ-5D-3L health states, for which several value sets exist. METHODS: Data from the 2012 Health Survey for England with complete GHQ-12 and EQ-5D-3L descriptive system response …
OBJECTIVE: The aim of this study was to create an item-response mapping between GHQ-12 and EQ-5D-3L health states, for which several …
58 results